Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells
- 1 December 1999
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 46 (3) , 197-202
- https://doi.org/10.1016/s0168-8227(99)00094-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High-glucose--triggered apoptosis in cultured endothelial cellsDiabetes, 1995
- Glycation and Diabetic ComplicationsDiabetes, 1994
- Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1993
- Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.Journal of Clinical Investigation, 1992
- Glycosylation Products as Toxic Mediators of Diabetic ComplicationsAnnual Review of Medicine, 1991
- Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.The Journal of Experimental Medicine, 1989
- Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-LinkingScience, 1986
- Nonenzymatic Glycosylation and the Pathogenesis of Diabetic ComplicationsAnnals of Internal Medicine, 1984
- Accelerated age-related browning of human collagen in diabetes mellitus.Proceedings of the National Academy of Sciences, 1984
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973